Neurology

The Pharmacy Times® Neurology resource center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?

FDA Committee Does Not Recommend Approval of Aducanumab for Alzheimer Disease

A final vote that assessed whether the findings from the EMERGE trial served as primary evidence for the efficacy of aducanumab in Alzheimer disease was 10–0 that the trial did not provide evidence.

New Migraine Drugs Target Triptan Contraindication Population

The current acute treatments for migraines have shown efficacy and safety, however, approximately one-third of people do not respond, cannot use these options due to contraindications, or report dissatisfaction in therapy.

N-acetylglucosamine May Promote Myelin Repair in Multiple Sclerosis

Simple sugar found in breast milk and dietary supplements may promote myelin repair in patients with multiple sclerosis.

Study: Multiple Sclerosis as the Flip Side of Immune Fitness

Approximately half of the people with multiple sclerosis (MS) have the HLA-DR15 gene variant, which is responsible for up to 60% of genetic risk.

The Impact of Physical Activity on Parkinson Disease Progression

Research has also shown that patients with Parkinson disease who are able to engage in physical activity can potentially improve the motor and non-motor symptoms associated with the disease.

Ubrelvy: Treatment for Acute Migraines With or Without Aura in Adults

Ubrogepant (Ubrelvy, Allergan) was approved for the treatment of acute migraines with or without aura in adults after showing a significantly greater reduction in headache pain compared with placebo.

Intranasal Anti-Inflammatory Drug Can Help Slow Multiple Sclerosis Disease Progression

VX-765, a novel multiple sclerosis drug, works by inhibiting a component of inflammasomes that promotes harmful inflammation.

Multiple Sclerosis Increases Risk of Unemployment

Several risk factors for multiple sclerosis, such as disease progression and fatigue, increase the risk of unemployment.

Women Who Are Fertile For Longer Have Higher Dementia Risk

Women who had longer reproductive periods during their lifetimes were found to have a greater risk of dementia in older age compared with those who had shorter reproductive periods.

Glenmark Receives FDA Approval for Generic Dimethyl Fumarate Capsules

Dimethyl fumarate is indicated to treat relapsing forms of multiple sclerosis in adult patients.

Health-System Specialty Pharmacies Address Social Determinants of Health

Integrating specialty pharmacy staff into oncology, neurology, rheumatology, and other specialty clinics within their health systems is a growing trend with a range of beneficial outcomes.

Study: Individuals with Preclinical Alzheimer Disease More Likely to Fall

Individuals with asymptomatic Alzheimer disease are more likely to fall than those who are not on track to develop dementia.

The Pharmacy Times® Neurology resource center provides a home for all of the latest clinical information that both neurologists and pharmacists that work within the field could find valuable. With articles covering updates from the robust pipeline of novel neurological therapies, and the newest data from all phases of clinical trials and studies in the space, it also serves as a hub of coverage from ongoing conferences and annual meetings of neurological associations.